Many anti-malaria drugs in Africa fake or substandard, reports show

"Many of Africa's anti-malaria drugs are fake or of poor quality, weakening a crucial battle against the world's deadliest disease, a new investigation has found," GlobalPost reports, adding, "Many of the drugs -- even those approved by the World Health Organization -- are Chinese fakes or low-quality variants that failed quality tests, according to two new studies released today" (Conway-Smith, 7/10). "Two studies published in Research and Reports in Tropical Medicine suggested manufacturing problems, rather than counterfeiting, may be to blame for these substandard drugs in low- and middle-income countries around the world," Agence France-Presse writes (7/10). Writing in a Business Day opinion piece published on Tuesday, "Roger Bate, lead author of the studies and a scholar at the conservative American Enterprise Institute, warned of 'unthinkable' public health consequences from drug resistance," GlobalPost notes.

The first study looked at "2,652 samples of antimalarials, antibiotics and tuberculosis drugs ... purchased in 11 African cities, three cities in India and five middle-income cities, including Beijing and Bangkok," and found "[u]p to 15 percent of all the drugs bought in Africa failed basic quality testing," and "[o]f the drugs that had received approval from the [WHO], seven percent failed the quality tests," GlobalPost writes. "The second study found that nearly eight percent of antimalarial drugs approved by the WHO or another 'stringent' regulatory authority, and sold in Accra, Ghana, and Lagos, Nigeria, failed quality tests because they contained too little of the active ingredient," the news service adds. "Bate told reporters in a conference call that the WHO has launched an investigation on the basis of his studies," GlobalPost notes (7/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A promising new strategy for malaria drug development